Therapeutic Inequivalency Action Coordinating Committee

7/8/2003


Click here to start


Table of Contents

PPT Slide

Therapeutic Inequivalency Action Coordinating Committee

The Mission of TIACC

Historical Overview

TIACC Membership (until 1995)

Current TIACC Membership

Potential Issue Sources

What Defines a Potential TIACC Issue? (Generally)

The Need For Increased TIACC Activity

Perception of Price ?

The Need for Enhancement

The TIACC “Radar Screen” A Proactive Approach

The Evaluation Team (ET) Approach

Responsibilities of OPS ET

Formal TIACC Action

TIACC Accomplishments

Partnership with Industry

Back to Meeting Agenda http://www.fda.gov/cder/ogd/GPHApresent.htm

Download presentation source